Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Patent Publication Number 20160206607
US 20160206607 A1Patent NumberUS 09993467 B2
Application Number14998262
Filled DateDec 23, 2015
Priority DateMay 19, 2009
Publication DateJul 21, 2016
Original AssigneeBristol Myers Squibb
Current AssigneeCelgene
Inventor/ApplicantsMichael T. Kelly
Anthony J. Tutino
Anthony J. Tutino
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.